US Stock MarketDetailed Quotes
MEDS Trxade Health
- 7.6900
- +0.7900+11.45%
Close Aug 14 16:00 ET
- 7.3100
- -0.3800-4.94%
Post 19:48 ET
11.22MMarket Cap0.79P/E (TTM)
7.8000High6.9500Low19.17KVolume6.9500Open6.9000Pre Close143.01KTurnover3.77%Turnover RatioLossP/E (Static)1.46MShares27.758752wk High0.95P/B3.91MFloat Cap2.298752wk Low--Dividend TTM508.99KShs Float108.3948Historical High--Div YieldTTM12.32%Amplitude2.2987Historical Low7.4580Avg Price1Lot Size
Trxade Health Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -94.90%18.7K | 0 | -19.30%8.27M | 4.26%2.35M | 0.11%2.06M | -88.82%366.53K | -84.78%493.32K | 3.65%10.25M | -5.51%2.26M | -19.38%2.06M |
| Operating revenue | -94.90%18.7K | --0 | -19.30%8.27M | 4.26%2.35M | 0.11%2.06M | -88.82%366.53K | -84.78%493.32K | 3.65%10.25M | -5.51%2.26M | -19.38%2.06M |
| Cost of revenue | -93.52%19.4K | 0 | 19.93%5.67M | 522.04%4.6M | -48.28%353.45K | -85.80%299.39K | -77.94%420.1K | -8.02%4.73M | -35.55%739.66K | -46.15%683.38K |
| Gross profit | -101.05%-703 | 0 | -52.92%2.6M | -248.26%-2.25M | 24.20%1.7M | -94.27%67.14K | -94.52%73.22K | 16.29%5.52M | 22.29%1.52M | 7.13%1.37M |
| Operating expense | 124.16%1.49M | 525.09%5.5M | 30.45%9.86M | 131.51%3.94M | 60.24%2.55M | -70.67%666.92K | -61.84%879.31K | -10.38%7.56M | 3.49%1.7M | -38.23%1.59M |
| Selling and administrative expenses | 120.28%1.41M | 551.35%5.44M | 29.21%8.48M | 155.30%3.58M | 58.15%2.14M | -67.64%639.34K | -59.41%835.59K | -12.86%6.57M | -1.63%1.4M | -39.54%1.35M |
| -General and administrative expense | 120.28%1.41M | 551.35%5.44M | 29.21%8.48M | 155.30%3.58M | 58.15%2.14M | -67.64%639.34K | -59.41%835.59K | -12.86%6.57M | -1.63%1.4M | -39.54%1.35M |
| Research and development costs | 214.28%86.67K | 23.20%53.86K | 38.64%1.38M | 21.24%366.53K | 72.11%410.61K | -90.75%27.58K | -82.21%43.72K | 10.39%993.19K | 36.42%302.31K | -29.55%238.58K |
| Operating profit | -149.37%-1.5M | -581.87%-5.5M | -255.92%-7.26M | -3,211.57%-6.19M | -286.33%-845.15K | 45.63%-599.78K | 16.78%-806.09K | 44.69%-2.04M | 53.94%-187.01K | 83.11%-218.76K |
| Net non-operating interest income expense | 119.96%36.08K | 38.84%-35.59K | -278.83%-1.19M | -284.42%-703.44K | -106.87%-251.78K | -1,874.16%-180.73K | -4,166.42%-58.19K | -1,236.23%-315.22K | -8,976.74%-182.99K | -2,064.91%-121.71K |
| Non-operating interest income | --41.03K | 1,398.83%62.92K | -80.00%4.2K | --0 | --0 | --0 | --4.2K | --20.99K | --12.59K | --8.4K |
| Non-operating interest expense | -97.26%4.95K | 57.90%98.52K | 256.43%1.2M | 259.67%703.44K | 93.52%251.78K | 1,874.16%180.73K | 4,474.19%62.39K | 1,325.21%336.21K | 9,601.39%195.58K | 2,214.25%130.11K |
| Other net income (expense) | 88.60%-165.13K | -305.67%-1.1M | -10,978.58%-5.26M | -9,596.38%-4.82M | 925.32K | -1.45M | -6,742.76%-272.35K | 97.04%-47.51K | 86.79%-49.71K | |
| Gain on sale of security | 88.60%-165.13K | -1,013.61%-729.89K | -117.98%-148.42K | --294.89K | --925.32K | ---1.45M | --79.89K | --825.54K | ---- | ---- |
| Special income (charges) | --0 | -6.45%-374.97K | -487.49%-5.13M | -486.02%-5.13M | --0 | --0 | -8,691.32%-352.24K | 45.53%-873.05K | 45.39%-875.25K | --0 |
| -Less:Impairment of capital assets | ---- | ---- | --5.13M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Write off | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -45.39%875.25K | ---- | ---- |
| -Gain on sale of property,plant,equipment | --0 | -6.45%-374.97K | --0 | --0 | --0 | --0 | -8,691.32%-352.24K | --2.2K | --0 | --0 |
| Other non- operating income (expenses) | ---- | ---- | --14.54K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 27.11%-1.62M | -483.91%-6.64M | -470.87%-13.72M | -2,691.52%-11.72M | 49.60%-171.61K | -100.41%-2.23M | -17.68%-1.14M | 54.79%-2.4M | 46.49%-419.7K | 73.84%-340.47K |
| Income tax | ||||||||||
| Net income | 7.14%-1.83M | 3,233.85%21.25M | -356.37%-17.84M | -799.13%-11.72M | -566.70%-3.53M | -77.56%-1.97M | 29.81%-677.95K | 26.45%-3.91M | -66.13%-1.3M | 59.38%-528.74K |
| Net income continuous Operations | 27.11%-1.62M | -483.91%-6.64M | -470.87%-13.72M | -2,691.52%-11.72M | 49.60%-171.61K | -100.41%-2.23M | -17.68%-1.14M | 54.79%-2.4M | 46.49%-419.7K | 73.84%-340.47K |
| Net income discontinuous operations | -182.30%-209.16K | 5,978.90%27.88M | -173.70%-4.12M | --0 | -1,681.24%-3.35M | --254.16K | --458.68K | ---1.51M | ---883.33K | ---188.27K |
| Minority interest income | 0 | 0 | 0 | -437.77K | -377.84K | -25.74K | ||||
| Net income attributable to the parent company | 7.14%-1.83M | 3,233.85%21.25M | -413.91%-17.84M | -1,166.34%-11.72M | -600.81%-3.53M | -82.22%-1.97M | 29.39%-677.95K | 34.68%-3.47M | -17.96%-925.19K | 61.36%-503K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 7.14%-1.83M | 3,233.85%21.25M | -413.91%-17.84M | -1,166.34%-11.72M | -600.81%-3.53M | -82.22%-1.97M | 29.39%-677.95K | 34.68%-3.47M | -17.96%-925.19K | 61.36%-503K |
| Basic earnings per share | -572.41%-1.3 | 30,530.84%20.49 | -279.67%-23.35 | -886.58%-14.7 | -402.20%-4.57 | 90.28%-0.1933 | 96.26%-0.0673 | 36.92%-6.15 | -10.37%-1.49 | 62.08%-0.91 |
| Diluted earnings per share | -572.41%-1.3 | 25,006.06%16.77 | -279.67%-23.35 | -886.58%-14.7 | -402.20%-4.57 | 90.28%-0.1933 | 96.26%-0.0673 | 36.92%-6.15 | -10.37%-1.49 | 62.08%-0.91 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg